Who owns NTRA? 13F holders and whale ownership
NTRA is tracked across public portfolios in Whale Analyzer. This page answers who owns NTRA, which top funds are buying NTRA, aggregate disclosed value, and recent position changes based on public data. Stanley Druckenmiller is the largest reported holder at $613M; the top five funds control 100.0% of reported ownership; institutions were net selling last quarter (2 increased, 3 reduced); the stock trades above the aggregate whale cost basis of $96.86. Top tracked holders include Stanley Druckenmiller, Philippe Laffont, Lee Ainslie, and Cathie Wood.
Continue to the live NTRA dashboardTop holders
| Investor | Reported value | Shares | Change |
|---|---|---|---|
| Stanley Druckenmiller 13F portfolio Duquesne Family Office holdings | $612.7M | 3.1M | Increased |
| Philippe Laffont 13F portfolio Coatue Management holdings | $508.3M | 2.5M | Reduced |
| Lee Ainslie 13F portfolio Maverick Capital holdings | $234.3M | 1.2M | Increased |
| Cathie Wood 13F portfolio ARK Investment Management holdings | $136.8M | 684.3K | Reduced |
| Samuel Isaly 13F portfolio OrbiMed Advisors holdings | $52.4M | 262.0K | Reduced |
Ownership concentration
Reported ownership of NTRA is highly concentrated across tracked institutions.
- Single largest holder: 39.7% of reported ownership
- Top 5 holders: 100.0%
- Top 10 holders: 100.0%
Whale activity this quarter
Across 5 tracked institutions, 3 reduced, 2 increased. Net positioning is net selling.
- Stanley Druckenmiller — Duquesne Family Office ($612.7M) (▲ 22.0% qoq shares) · avg cost $49.21
- Philippe Laffont — Coatue Management ($508.3M) (▼ 3.5% qoq shares) · avg cost $193.40
- Lee Ainslie — Maverick Capital ($234.3M) (▲ 24.1% qoq shares) · avg cost $41.34
- Cathie Wood — ARK Investment Management ($136.8M) (▼ 6.4% qoq shares) · avg cost $46.63
- Samuel Isaly — OrbiMed Advisors ($52.4M) (▼ 28.4% qoq shares)
Whale cost basis vs current price
The aggregate tracked cost basis is $96.86 versus a current price of $261.91, so NTRA trades above its cost basis (+170.4%). Average unrealized P&L across tracked holders: 264%.
Sector positioning — Health Care
NTRA sits within the Health Care sector alongside 221 other tracked names. Compare whale ownership across peers:
How to use this page
Values are reported public positions from tracked 13F filers and disclosures — not real-time ownership totals. Open the live NTRA dashboard for price charts and cross-investor scans, or read the SEC 13F guide.
Related stock holder pages
- INSM whale holders — Insmed Inc
- TSMWF whale holders — Taiwan Semiconductor Manufac
- YPF whale holders — Ypf Sociedad Anonima
- EWZ whale holders — Ishares Inc
- TBBB whale holders — Bbb Foods Inc
- AA whale holders — Alcoa Corp
- NAMSW whale holders — Newamsterdam Pharma Company
- SE whale holders — Sea Ltd
Learn more in Whale Analyzer Academy
Deepen your read on NTRA with these Whale Analyzer Academy guides:
Frequently asked questions
Who owns NTRA stock?
Whale Analyzer tracks 5 public institutional holders of NTRA with a combined reported value of $1.54B. See the holder table above for the largest tracked positions.
Which top funds are buying NTRA?
Tracked institutions were net selling last quarter — 3 reduced, 2 increased. Check the "Change" column: "New" = fresh position, "Increased" = added, "Reduced" = trimmed.
How concentrated is NTRA ownership?
The top five tracked holders report 100.0% of aggregate ownership.
Is NTRA above or below the whale cost basis?
The aggregate tracked cost basis is $96.86 versus a current price of $261.91 (+170.4%).
What does 13F ownership mean for NTRA?
Use the interactive NTRA dashboard on Whale Analyzer for real-time holder analysis, or read our 13F Alpha Signals Guide.